Bank of New York Mellon’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
+60,065
| New | +$234K | ﹤0.01% | 3898 |
|
|
2024
Q2 | – | Sell |
-24,000
| Closed | -$66.5K | – | 4155 |
|
|
2024
Q1 | $66.5K | Sell |
24,000
-10,233
| -30% | -$28.3K | ﹤0.01% | 4057 |
|
|
2023
Q4 | $97.2K | Sell |
34,233
-384
| -1% | -$1.09K | ﹤0.01% | 4084 |
|
|
2023
Q3 | $89.3K | Sell |
34,617
-1,277
| -4% | -$3.3K | ﹤0.01% | 4087 |
|
|
2023
Q2 | $155K | Sell |
35,894
-168
| -0.5% | -$726 | ﹤0.01% | 4022 |
|
|
2023
Q1 | $55.2K | Hold |
36,062
| – | – | ﹤0.01% | 4173 |
|
|
2022
Q4 | $57K | Sell |
36,062
-186
| -0.5% | -$294 | ﹤0.01% | 4215 |
|
|
2022
Q3 | $45K | Hold |
36,248
| – | – | ﹤0.01% | 4339 |
|
|
2022
Q2 | $73K | Sell |
36,248
-164
| -0.5% | -$330 | ﹤0.01% | 4289 |
|
|
2022
Q1 | $91K | Sell |
36,412
-13,472
| -27% | -$33.7K | ﹤0.01% | 4420 |
|
|
2021
Q4 | $186K | Hold |
49,884
| – | – | ﹤0.01% | 4291 |
|
|
2021
Q3 | $200K | Buy |
49,884
+11,600
| +30% | +$46.5K | ﹤0.01% | 4211 |
|
|
2021
Q2 | $170K | Sell |
38,284
-2,292
| -6% | -$10.2K | ﹤0.01% | 4126 |
|
|
2021
Q1 | $371K | Sell |
40,576
-2,329
| -5% | -$21.3K | ﹤0.01% | 3830 |
|
|
2020
Q4 | $435K | Buy |
42,905
+29,433
| +218% | +$298K | ﹤0.01% | 3683 |
|
|
2020
Q3 | $57K | Hold |
13,472
| – | – | ﹤0.01% | 4005 |
|
|
2020
Q2 | $93K | Buy |
+13,472
| New | +$93K | ﹤0.01% | 3912 |
|